Cantharidin treatment can inhibit tumor cell proliferation and induce autophagy. Combination therapy with cantharidin and TRAIL may be a successful strategy for treating TRAIL-resistant prostate cancer. This evidence concerns the gene TNFSF10 and Familial prostate cancer.